Esperion Therapeutics, Inc. — All Filings
875 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
4
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRSLTR
EFFECT
FWP
NT 10-Q
PRE 14A
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 3 | FORM 3 - | 0001179110-13-010864 | Jun 25, 2013 | — |
| 3 | FORM 3 - | 0001179110-13-010863 | Jun 25, 2013 | — |
| CT ORDER | — | 9999999997-13-010996 | Jun 25, 2013 | — |
| 8-A12B | 8-A12B | 0001104659-13-051204 | Jun 25, 2013 | — |
| 3 | PRIMARY DOCUMENT | 0000904454-13-000721 | Jun 25, 2013 | — |
| EFFECT | — | 9999999995-13-001908 | Jun 25, 2013 | — |
| CORRESP | — | 0001104659-13-050677 | Jun 21, 2013 | — |
| CORRESP | — | 0001104659-13-050692 | Jun 21, 2013 | — |
| S-1/A | S-1/A | 0001047469-13-006896 | Jun 12, 2013 | — |
| S-1/A | S-1/A | 0001047469-13-006837 | Jun 7, 2013 | — |
| UPLOAD | — | 0000000000-13-030213 | Jun 3, 2013 | — |
| S-1 | S-1 | 0001047469-13-006083 | May 14, 2013 | — |
| UPLOAD | — | 0000000000-13-025380 | May 8, 2013 | — |
| D | — | 0001434868-13-000004 | Apr 26, 2013 | — |
| DRS | — | 0000912057-13-000117 | Apr 12, 2013 | — |
| DRSLTR | — | 0001410578-13-000100 | Apr 12, 2013 | — |
| D/A | — | 0001434868-11-000001 | Feb 11, 2011 | — |
| D/A | — | 0001434868-10-000005 | Feb 12, 2010 | — |
| REGDEX | AUTO-GENERATED PAPER DOCUMENT | 9999999997-08-023513 | May 7, 2008 | — |